Literature DB >> 22328840

Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis.

A Bagnato1, L Rosanò.   

Abstract

Entities:  

Keywords:  Ovarian carcinoma; Snail; chemoresistance; endothelin; epithelial-to-mesenchymal transition

Year:  2012        PMID： 22328840      PMCID： PMC3267589          DOI： 10.3747/co.19.895

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  14 in total

Review 1.  The importance of endothelin axis in initiation, progression, and therapy of ovarian cancer.

Authors:  Laura Rosanò; Francesca Spinella; Anna Bagnato
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

2.  Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.

Authors:  Laura Rosanò; Roberta Cianfrocca; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Alessandro Lucidi; Gabriella Ferrandina; Pier Giorgio Natali; Anna Bagnato
Journal:  Clin Cancer Res       Date:  2011-01-10       Impact factor: 12.531

3.  Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.

Authors:  Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Shoukat Dedhar; Antonio Garcia de Herreros; Pier Giorgio Natali; Anna Bagnato
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

4.  Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.

Authors:  Xianghong Wang; Ming Tat Ling; Xin-Yuan Guan; Sai Wah Tsao; Hiu Wing Cheung; Davy Tak Lee; Yong Chuan Wong
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

Review 5.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

6.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

7.  Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

Authors:  Hiroaki Kajiyama; Kiyosumi Shibata; Mikio Terauchi; Mamoru Yamashita; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Int J Oncol       Date:  2007-08       Impact factor: 5.650

8.  Snail is critical for tumor growth and metastasis of ovarian carcinoma.

Authors:  Hongyan Jin; Yinhua Yu; Tao Zhang; Xianrong Zhou; Jiayi Zhou; Luoqi Jia; Yadi Wu; Binhua P Zhou; Youji Feng
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients.

Authors:  S Hosono; H Kajiyama; M Terauchi; K Shibata; K Ino; A Nawa; F Kikkawa
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640
View more
  12 in total

Review 1.  Simulating cancer growth with multiscale agent-based modeling.

Authors:  Zhihui Wang; Joseph D Butner; Romica Kerketta; Vittorio Cristini; Thomas S Deisboeck
Journal:  Semin Cancer Biol       Date:  2014-05-02       Impact factor: 15.707

2.  Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance.

Authors:  Song Gao; Xiaoyun Zhao; Bei Lin; Zhenhua Hu; Limei Yan; Jian Gao
Journal:  Tumour Biol       Date:  2012-06-10

3.  Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.

Authors:  Kanchan Vishnoi; Sutapa Mahata; Abhishek Tyagi; Arvind Pandey; Gaurav Verma; Mohit Jadli; Tejveer Singh; Sukh Mahendra Singh; Alok C Bharti
Journal:  Tumour Biol       Date:  2016-07-24

4.  Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer.

Authors:  Branka Petrić Miše; Vesna Dobrić Telesmanić; Snježana Tomić; Dinka Šundov; Vesna Čapkun; Eduard Vrdoljak
Journal:  Pathol Oncol Res       Date:  2014-08-11       Impact factor: 3.201

5.  Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.

Authors:  Liza Makowski; Chunxiao Zhou; Yan Zhong; Pei Fen Kuan; Cheng Fan; Brante P Sampey; Megan Difurio; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

6.  Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.

Authors:  Mohammed Najim Abed; Marwan Ibrahim Abdullah; Alan Richardson
Journal:  J Ovarian Res       Date:  2016-04-14       Impact factor: 4.234

7.  Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.

Authors:  Shailendra Kumar Dhar Dwivedi; Soumyajit Banerjee Mustafi; Lingegowda S Mangala; Dahai Jiang; Sunila Pradeep; Cristian Rodriguez-Aguayo; Hui Ling; Cristina Ivan; Priyabrata Mukherjee; George A Calin; Gabriel Lopez-Berestein; Anil K Sood; Resham Bhattacharya
Journal:  Oncotarget       Date:  2016-03-22

8.  HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies.

Authors:  Haneen Amawi; Noor A Hussein; Chandrabose Karthikeyan; Elangovan Manivannan; Alexander Wisner; Frederick E Williams; Temesgen Samuel; Piyush Trivedi; Charles R Ashby; Amit K Tiwari
Journal:  Front Pharmacol       Date:  2017-08-02       Impact factor: 5.810

Review 9.  Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.

Authors:  Robert Cornelison; Danielle C Llaneza; Charles N Landen
Journal:  Int J Mol Sci       Date:  2017-10-18       Impact factor: 5.923

10.  Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.

Authors:  Jian-peng Teoh; Kyoung-mi Park; Yongchao Wang; Qiuping Hu; Sangmi Kim; Guangyu Wu; Shuang Huang; Nita Maihle; Il-man Kim
Journal:  Cell Signal       Date:  2014-09-03       Impact factor: 4.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.